Pages that link to "Q39703229"
Jump to navigation
Jump to search
The following pages link to The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles (Q39703229):
Displaying 50 items.
- Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines (Q27002209) (← links)
- Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities (Q27011598) (← links)
- Enhancing Tumor Penetration of Nanomedicines. (Q30356887) (← links)
- Extracellularly activatable nanocarriers for drug delivery to tumors. (Q30401826) (← links)
- Radioactive 198Au-doped nanostructures with different shapes for in vivo analyses of their biodistribution, tumor uptake, and intratumoral distribution (Q30413615) (← links)
- Remotely triggered cisplatin release from carbon nanocapsules by radiofrequency fields. (Q30443489) (← links)
- Doxorubicin as a Molecular Nanotheranostic Agent: Effect of Doxorubicin Encapsulation in Micelles or Nanoemulsions on the Ultrasound-Mediated Intracellular Delivery and Nuclear Trafficking (Q30472420) (← links)
- A computational framework for identifying design guidelines to increase the penetration of targeted nanoparticles into tumors (Q33855309) (← links)
- Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. (Q34447986) (← links)
- Polyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect (Q34532194) (← links)
- Intratumoral Drug Delivery with Nanoparticulate Carriers (Q35091415) (← links)
- A highly tumor-targeted nanoparticle of podophyllotoxin penetrated tumor core and regressed multidrug resistant tumors. (Q35232504) (← links)
- Cancer theranostics with gold nanoshells. (Q35364515) (← links)
- In vivo tumor targeting by a NGR-decorated micelle of a recombinant diblock copolypeptide (Q35377628) (← links)
- Nanomedicine as an emerging approach against intracellular pathogens (Q35656908) (← links)
- Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery. (Q35924007) (← links)
- The shape of things to come: importance of design in nanotechnology for drug delivery (Q36128678) (← links)
- Design considerations for nanotherapeutics in oncology (Q36236848) (← links)
- Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy (Q36673747) (← links)
- Nanoscale Drug Delivery Systems for Enhanced Drug Penetration into Solid Tumors: Current Progress and Opportunities (Q36803827) (← links)
- Solid Tumor Therapy Using a Cannon and Pawn Combination Strategy. (Q36926018) (← links)
- Targeted polymeric therapeutic nanoparticles: design, development and clinical translation (Q36934007) (← links)
- Microdistribution of MC1R-targeted polyplexes in murine melanoma tumor tissue. (Q37230140) (← links)
- Development and in vivo quantitative magnetic resonance imaging of polymer micelles targeted to the melanocortin 1 receptor. (Q37254458) (← links)
- Photoswitchable nanoparticles for in vivo cancer chemotherapy (Q37340860) (← links)
- Polymeric Micelles for Neoadjuvant Cancer Therapy and Tumor-Primed Optical Imaging (Q37427858) (← links)
- Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles (Q37476252) (← links)
- Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. (Q37529131) (← links)
- Tumour-on-a-chip provides an optical window into nanoparticle tissue transport. (Q37626346) (← links)
- Molecular Nanomedicine Towards Cancer: 111In-Labeled Nanoparticles (Q38001309) (← links)
- Tailoring Polymeric Micelles to Optimize Delivery to Solid Tumors (Q38038896) (← links)
- Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. (Q38067265) (← links)
- The holistic 3M modality of drug delivery nanosystems for cancer therapy (Q38071901) (← links)
- Intracellular delivery of polymeric nanocarriers: a matter of size, shape, charge, elasticity and surface composition (Q38112171) (← links)
- In vivo applications of magnetic nanoparticle hyperthermia (Q38161993) (← links)
- Core-shell nanocarriers for cancer therapy. Part I: biologically oriented design rules (Q38169195) (← links)
- Guiding principles in the design of ligand-targeted nanomedicines. (Q38189490) (← links)
- Effect of size on biological properties of nanoparticles employed in gene delivery (Q38215364) (← links)
- Plasma and cellular pharmacokinetic considerations for the development and optimization of antitumor block copolymer micelles (Q38248809) (← links)
- Principles in the design of ligand-targeted cancer therapeutics and imaging agents. (Q38362491) (← links)
- In vitro microfluidic models of tumor microenvironment to screen transport of drugs and nanoparticles (Q38405765) (← links)
- Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors (Q38567353) (← links)
- Scientific and industrial challenges of developing nanoparticle-based theranostics and multiple-modality contrast agents for clinical application (Q38591130) (← links)
- Polymeric Nanoparticles for Cancer Photodynamic Therapy. (Q38640933) (← links)
- The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies. (Q38645695) (← links)
- Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis? (Q38755295) (← links)
- The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction (Q38784932) (← links)
- EGF-liposomes promote efficient EGFR targeting in xenograft colocarcinoma model (Q38792917) (← links)
- Macrophages as Active Nanocarriers for Targeted Early and Adjuvant Cancer Chemotherapy. (Q38827940) (← links)
- Coadministration of Vascular Disrupting Agents and Nanomedicines to Eradicate Tumors from Peripheral and Central Regions (Q38881452) (← links)